Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 5/20 | 0.72 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | RGS12 | O14924 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2999416 | 1.00 | SRD5A2 (0.72) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL1145770 | 0.94 | SRD5A2 (0.83) | SRD5A2NR3C1AKR1B1FFAR1LMNA | |
| SCHEMBL2353788 | 0.92 | CA2 (0.76) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL11562567 | 0.90 | SRD5A2 (0.62) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL5924483 | 0.90 | SRD5A2 (0.62) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL6441891 | 0.90 | SRD5A2 (0.62) | SRD5A2NR3C1CA2CAMK2AFFAR1 | |
| SCHEMBL3500048 | 0.90 | SRD5A2 (0.62) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL16866564 | 0.88 | SRD5A2 (0.60) | SRD5A2NR3C1CA2CAMK2AAKR1B1 | |
| SCHEMBL8969156 | 0.88 | SRD5A2 (0.70) | SRD5A2NR3C1AKR1B1FFAR1LMNA | |
| SCHEMBL21753830 | 0.88 | SRD5A2 (0.75) | SRD5A2NR3C1AKR1B1FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312812-A1 | EPOXY RESIN | THE BOEING COMPANY | 2023-10-05 | — | — | US | disclosed |
| US-11718707-B2 | Epoxy resin | THE BOEING COMPANY (US) | 2023-08-08 | — | — | US | disclosed |
| EP-4148047-A1 | EPOXY RESIN | The Boeing Company (US) | 2023-03-15 | — | — | EP | disclosed |
| US-20210355269-A1 | EPOXY RESIN | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-11-18 | — | — | US | disclosed |
| US-11059937-B2 | Epoxy resin | THE BOEING COMPANY (US) | 2021-07-13 | — | — | US | disclosed |
| US-20190248953-A1 | EPOXY RESIN | THE BOEING COMPANY | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718707-B2 | Epoxy resin | EPHX2, EPHX1, CBR1 | SRD5A2 1255/4885NR3C1 1767/4885CA2 4706/4885 |
| US-20210355269-A1 | EPOXY RESIN | EPHX2, EPHX1, CBR1 | SRD5A2 1255/4885NR3C1 1767/4885CA2 4706/4885 |
| US-20190248953-A1 | EPOXY RESIN | EPHX2, EPHX1, CBR1 | SRD5A2 1255/4885NR3C1 1767/4885CA2 4706/4885 |
| US-11059937-B2 | Epoxy resin | EPHX2, EPHX1, CBR1 | SRD5A2 1255/4885NR3C1 1767/4885CA2 4706/4885 |
| US-20230312812-A1 | EPOXY RESIN | EPHX2, EPHX1, CBR1 | SRD5A2 1255/4885NR3C1 1767/4885CA2 4706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.